Sharma, Ajay <br/><br/>
Attenuation of corneal myofibroblast development through nanoparticle-mediated soluble transforming growth factor-β type II receptor (sTGFβRII) gene transfer.  [electronic resource] 

 -  Molecular vision  2012 
 - 2598-607 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1090-0535 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actins--biosynthesis<br/>Apoptosis--drug effects<br/>Cell Survival--drug effects<br/>Cells, Cultured<br/>Cornea--drug effects<br/>Fibrosis--chemically induced<br/>Humans<br/>Immunoglobulin Fc Fragments--chemistry<br/>Lipids--chemistry<br/>Myofibroblasts--drug effects<br/>Nanoparticles--chemistry<br/>Plasmids--chemistry<br/>Polyethyleneimine--chemistry<br/>Protein Serine-Threonine Kinases--chemistry<br/>Receptor, Transforming Growth Factor-beta Type II<br/>Receptors, Transforming Growth Factor beta--chemistry<br/>Solubility<br/>Transfection--methods<br/>Transforming Growth Factor beta1--adverse effects